Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Rankning i aktier
#3609
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Aktiekurs
$3.74
Marknadsvärde
$4.73B
Förändring (1 dag)
0.74%
Förändring (1 år)
-51.90%
Land
CN
Handel Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Kategori
Healthcare
Antal utestående aktier för Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Antal utestående aktier per June 2026: 1.26B
Enligt de senaste finansiella rapporterna och aktiekursen för Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. är det aktuella antalet utestående aktier 1.26B. I slutet av December 2023 hade företaget 1.26B utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392) från 2013 till 2026
Utestående aktier vid slutet av varje år
| År | Utestående aktier | Ändra |
|---|---|---|
| 2026 (TTM) | 1.26B | -4.79% |
| 2024 | 1.33B | 5.37% |
| 2023 | 1.26B | 0.86% |
| 2022 | 1.25B | 1.55% |
| 2021 | 1.23B | 2.96% |
| 2020 | 1.20B | 8.71% |
| 2019 | 1.10B | 2.96% |
| 2018 | 1.07B | 4.91% |
| 2017 | 1.02B | -0.91% |
| 2016 | 1.03B | -0.11% |
| 2015 | 1.03B | 0.76% |
| 2014 | 1.02B | 3.41% |
| 2013 | 986.72M | 0.00% |
Utestående aktier för liknande företag eller konkurrenter
| Företag | Utestående aktier | Skillnad | Land |
|---|---|---|---|
| 253.90M | -79.92% |
US
|
|
| 396.00M | -68.68% |
US
|
|
| 478.91M | -62.12% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -95.08% |
NL
|
